Prelude Therapeutics Inc (PRLD) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $67.0K | -91.2% |
| 2024 | $764.0K | -78.3% |
| 2023 | $3.51M | +16.4% |
| 2022 | $3.02M | +30.0% |
| 2021 | $2.32M | +274.1% |
| 2020 | $621.0K | -20.4% |
| 2019 | $780.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $67.0K | -91.2% |
| 2024 | $764.0K | -78.3% |
| 2023 | $3.51M | +16.4% |
| 2022 | $3.02M | +30.0% |
| 2021 | $2.32M | +274.1% |
| 2020 | $621.0K | -20.4% |
| 2019 | $780.0K | — |